How we approach: Severe congenital neutropenia and myelofibrosis due to mutations in VPS45

Mutations in the VPS45 gene lead to a severe primary immune deficiency characterized by severe congenital neutropenia and primary myelofibrosis, leading to overwhelming infection and early death. This condition is exceedingly rare with only 16 patients previously reported, including four with successful hematopoietic stem cell transplantation. We review the pathophysiology underlying this condition and detail our approach to treatment, particularly vis‐à‐vis bone marrow transplantation and the challenges of transplanting into a diseased bone marrow niche. We provide an update on the progress of our three previously reported patients, and two additional patients transplanted at our center.

[1]  P. Newburger,et al.  A novel homozygous VPS45 p.P468L mutation leading to severe congenital neutropenia with myelofibrosis , 2017, Pediatric blood & cancer.

[2]  K. Welte,et al.  Severe congenital neutropenias , 2017, Nature Reviews Disease Primers.

[3]  C. Klein,et al.  Severe congenital neutropenia with neurological impairment due to a homozygous VPS45 p.E238K mutation: A case report suggesting a genotype–phenotype correlation , 2015, American journal of medical genetics. Part A.

[4]  Anneliese O. Speak,et al.  Gray platelet syndrome: proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice. , 2014, Blood.

[5]  S. Corey,et al.  Cellular stress pathways in pediatric bone marrow failure syndromes: many roads lead to neutropenia , 2014, Pediatric Research.

[6]  D. Mevorach,et al.  VPS 45‐associated primary infantile myelofibrosis – Successful treatment with hematopoietic stem cell transplantation , 2013, Pediatric transplantation.

[7]  J. Mullikin,et al.  A congenital neutrophil defect syndrome associated with mutations in VPS45. , 2013, The New England journal of medicine.

[8]  A. Borkhardt,et al.  The Thr224Asn mutation in the VPS45 gene is associated with the congenital neutropenia and primary myelofibrosis of infancy. , 2013, Blood.

[9]  T. Moore,et al.  Stem Cell Transplantation in Primary Myelofibrosis of Childhood , 2013, Journal of pediatric hematology/oncology.

[10]  A. Bertuch,et al.  Clinical, histopathologic, and genetic features of pediatric primary myelofibrosis—An entity different from adults , 2012, American journal of hematology.

[11]  N. Naslavsky,et al.  Common and distinct roles for the binding partners Rabenosyn-5 and Vps45 in the regulation of endocytic trafficking in mammalian cells. , 2010, Experimental cell research.

[12]  K. Gengyo-Ando,et al.  The SM protein VPS‐45 is required for RAB‐5‐dependent endocytic transport in Caenorhabditis elegans , 2007, EMBO reports.

[13]  M. Verhage,et al.  Vesicle trafficking: pleasure and pain from SM genes. , 2003, Trends in cell biology.

[14]  D. James,et al.  Vps45p stabilizes the syntaxin homologue Tlg2p and positively regulates SNARE complex formation , 2001, The EMBO journal.